InfuSystem Holdings, Inc. (INFU) DCF Valuation
- ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
- ✓ Design Profissional: Modelos Confiáveis E Padrão Da Indústria
- ✓ Pré-Construídos Para Uso Rápido E Eficiente
- ✓ Não É Necessária Experiência; Fácil De Seguir
InfuSystem Holdings, Inc. (INFU) Bundle
Simplify InfuSystem Holdings, Inc. (INFU) valuation with this customizable DCF Calculator! Featuring real InfuSystem Holdings, Inc. (INFU) financials and adjustable forecast inputs, you can test scenarios and uncover InfuSystem Holdings, Inc. (INFU) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 81.1 | 97.4 | 102.4 | 109.9 | 125.8 | 140.6 | 157.1 | 175.5 | 196.1 | 219.2 |
Revenue Growth, % | 0 | 20.06 | 5.13 | 7.36 | 14.44 | 11.75 | 11.75 | 11.75 | 11.75 | 11.75 |
EBITDA | 15.8 | 22.8 | 17.2 | 15.1 | 16.5 | 24.3 | 27.2 | 30.4 | 33.9 | 37.9 |
EBITDA, % | 19.44 | 23.44 | 16.75 | 13.73 | 13.11 | 17.29 | 17.29 | 17.29 | 17.29 | 17.29 |
Depreciation | 12.3 | 14.0 | 14.6 | 13.4 | 12.5 | 18.6 | 20.7 | 23.2 | 25.9 | 28.9 |
Depreciation, % | 15.22 | 14.4 | 14.28 | 12.15 | 9.94 | 13.2 | 13.2 | 13.2 | 13.2 | 13.2 |
EBIT | 3.4 | 8.8 | 2.5 | 1.7 | 4.0 | 5.8 | 6.4 | 7.2 | 8.0 | 9.0 |
EBIT, % | 4.23 | 9.03 | 2.47 | 1.57 | 3.17 | 4.09 | 4.09 | 4.09 | 4.09 | 4.09 |
Total Cash | 2.6 | 9.6 | .2 | .2 | .2 | 3.8 | 4.3 | 4.8 | 5.4 | 6.0 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 12.1 | 14.7 | 15.4 | 16.9 | 19.8 | 21.4 | 23.9 | 26.7 | 29.9 | 33.4 |
Account Receivables, % | 14.91 | 15.11 | 15.05 | 15.35 | 15.76 | 15.24 | 15.24 | 15.24 | 15.24 | 15.24 |
Inventories | 2.9 | 3.0 | 3.9 | 4.8 | 6.4 | 5.6 | 6.3 | 7.0 | 7.8 | 8.8 |
Inventories, % | 3.57 | 3.08 | 3.85 | 4.39 | 5.09 | 4 | 4 | 4 | 4 | 4 |
Accounts Payable | 8.0 | 6.8 | 7.9 | 8.3 | 8.0 | 10.8 | 12.1 | 13.5 | 15.1 | 16.8 |
Accounts Payable, % | 9.82 | 6.96 | 7.68 | 7.59 | 6.37 | 7.68 | 7.68 | 7.68 | 7.68 | 7.68 |
Capital Expenditure | -22.6 | -16.9 | -16.7 | -15.1 | -1.0 | -21.4 | -23.9 | -26.7 | -29.8 | -33.3 |
Capital Expenditure, % | -27.86 | -17.37 | -16.27 | -13.72 | -0.81409 | -15.2 | -15.2 | -15.2 | -15.2 | -15.2 |
Tax Rate, % | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 | 52.89 |
EBITAT | 3.1 | 20.2 | 2.9 | .2 | 1.9 | 4.0 | 4.5 | 5.0 | 5.6 | 6.3 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -14.2 | 13.4 | .3 | -3.3 | 8.5 | 3.2 | -.5 | -.6 | -.7 | -.8 |
WACC, % | 10.28 | 10.39 | 10.39 | 9.51 | 9.85 | 10.08 | 10.08 | 10.08 | 10.08 | 10.08 |
PV UFCF | ||||||||||
SUM PV UFCF | 1.1 | |||||||||
Long Term Growth Rate, % | 4.00 | |||||||||
Free cash flow (T + 1) | -1 | |||||||||
Terminal Value | -13 | |||||||||
Present Terminal Value | -8 | |||||||||
Enterprise Value | -7 | |||||||||
Net Debt | 36 | |||||||||
Equity Value | -43 | |||||||||
Diluted Shares Outstanding, MM | 22 | |||||||||
Equity Value Per Share | -2.00 |
What You Will Get
- Real INFU Financial Data: Pre-filled with InfuSystem's historical and projected data for precise analysis.
- Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
- Automatic Calculations: See InfuSystem's intrinsic value update instantly based on your changes.
- Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
- User-Friendly Design: Simple structure and clear instructions for all experience levels.
Key Features
- Customizable Financial Inputs: Adjust essential variables such as revenue projections, EBITDA margins, and capital investments.
- Instant DCF Valuation: Automatically computes intrinsic value, NPV, and other financial metrics in real-time.
- High-Precision Accuracy: Leverages InfuSystem's actual financial data for dependable valuation results.
- Easy Scenario Testing: Effortlessly evaluate various assumptions and analyze different outcomes.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- 1. Access the Template: Download and open the Excel file containing InfuSystem Holdings, Inc. (INFU) preloaded data.
- 2. Modify Assumptions: Adjust critical inputs such as growth rates, WACC, and capital expenditures.
- 3. Analyze Results Instantly: The DCF model automatically calculates intrinsic value and NPV.
- 4. Explore Scenarios: Evaluate various forecasts to understand different valuation possibilities.
- 5. Present with Confidence: Deliver professional valuation insights to enhance your decision-making process.
Why Choose This Calculator?
- Designed for Industry Experts: A sophisticated tool utilized by analysts, CFOs, and consultants.
- Accurate Data: InfuSystem's historical and projected financials preloaded for precision.
- Scenario Analysis: Effortlessly simulate various forecasts and assumptions.
- Comprehensive Outputs: Automatically computes intrinsic value, NPV, and essential metrics.
- User-Friendly: Step-by-step guidance leads you through the calculations.
Who Should Use InfuSystem Holdings, Inc. (INFU)?
- Healthcare Investors: Make informed investment choices with reliable data on InfuSystem's performance.
- Market Analysts: Streamline your analysis process with comprehensive reports on INFU's market position.
- Consultants: Easily modify presentations or reports to include insights on InfuSystem's services.
- Healthcare Enthusiasts: Enhance your knowledge of the healthcare sector with real-life case studies involving INFU.
- Educators and Students: Utilize it as a practical resource for coursework in healthcare finance and management.
What the Template Contains
- Preloaded INFU Data: Historical and projected financial data, including revenue, EBIT, and capital expenditures.
- DCF and WACC Models: Professional-grade sheets for calculating intrinsic value and Weighted Average Cost of Capital.
- Editable Inputs: Yellow-highlighted cells for adjusting revenue growth, tax rates, and discount rates.
- Financial Statements: Comprehensive annual and quarterly financials for deeper analysis.
- Key Ratios: Profitability, leverage, and efficiency ratios to evaluate performance.
- Dashboard and Charts: Visual summaries of valuation outcomes and assumptions.